In the final episode, experts at UCSD and La Jolla Institute discuss current clinical trials of a cancer vaccine and future directions for neoantigen vaccines. Custom-made Cancer Therapy: Neoantigen ...
Ikhimiukor et al. investigate the plasmid backgrounds of colistin resistance genes mcr-9 and mcr-10 at both hospital-level and global level. Plasmid-borne mcr-9.1 and mcr-9.2 alleles are carried by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback